Cargando…

NT Pro‐BNP can be used as a risk predictor of clinical atrial fibrillation with or without left atrial enlargement

BACKGROUND: NT Pro‐BNP is a blood marker secreted by cardiomyocytes. Myocardial stretch is the main factor to stimulate NT Pro‐BNP secretion in cardiomyocytes. NT Pro‐BNP is an important risk factor for cardiac dysfunction, stroke, and pulmonary embolism. So does atrial myocyte stretching occur when...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Xiao, Li, Hao, Liu, Cai, Ren, Yuanyuan, Sun, Chaofeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8799051/ https://www.ncbi.nlm.nih.gov/pubmed/34952980 http://dx.doi.org/10.1002/clc.23760

Ejemplares similares

Left atrial diameter and atrial fibrillation, but not elevated NT-proBNP, predict the development of pulmonary hypertension in patients with HFpEF
por: LIU, Yi-Xian, et al.
Publicado: (2020)

Baseline NT-ProBNP level predicts success of cardioversion of atrial fibrillation with flecainide
por: Amin, Ahmad Shoaib, et al.
Publicado: (2015)

Joint Associations of Obesity and NT‐proBNP With the Incidence of Atrial Fibrillation in the ARIC Study
por: Almuwaqqat, Zakaria, et al.
Publicado: (2019)

Total NT-proBNP, a novel biomarker related to recurrent atrial fibrillation
por: Staszewsky, Lidia, et al.
Publicado: (2021)

NT-pro-BNP as a Predictor for Recurrence of Atrial Fibrillation after Primary Cryoballoon Pulmonary Vein Isolation
por: Blessberger, Hermann, et al.
Publicado: (2022)

miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation
por: Sieweke, Jan-Thorben, et al.
Publicado: (2020)

Pericardial NT-Pro-BNP and GDF-15 as Biomarkers of Atrial Fibrillation and Atrial Matrix Remodeling in Aortic Stenosis
por: Fragão-Marques, Mariana, et al.
Publicado: (2021)

NT‐proBNP as a Mediator of the Racial Difference in Incident Atrial Fibrillation and Heart Failure
por: Whitman, Isaac R., et al.
Publicado: (2019)

Effects of Atrial Fibrillation on Heart Failure Outcomes and NT-proBNP Levels in the GUIDE-IT Trial
por: Chouairi, Fouad, et al.
Publicado: (2021)

Changes in Serum NT-Pro BNP and Left Atrial BNP Levels after Percutaneous Transvenous Mitral Commissurotomy in Sinus Rhythm Versus Atrial Firilation
por: Pourafkari, Leili, et al.
Publicado: (2014)

The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2019)

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials
por: Werhahn, Stefanie M., et al.
Publicado: (2021)

Atrioventricular block can be used as a risk predictor of clinical atrial fibrillation
por: Zhao, Xiao, et al.
Publicado: (2019)

Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP – A narrative review
por: Kerr, Brian, et al.
Publicado: (2022)

NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis
por: Reinhard, Henrik, et al.
Publicado: (2011)

Correction to: The influence of atrial fibrillation on the levels of NT-proBNP versus GDF-15 in patients with heart failure
por: Santema, Bernadet T., et al.
Publicado: (2020)

Correlation of NT-proBNP and left atrial pressure in patients with atypical atrial flutter after cardiac surgery and previous catheter ablation
por: Bakytzhanuly, A, et al.
Publicado: (2023)

NT Pro BNP Plasma Level and Atrial Volume Are Linked to the Severity of Liver Cirrhosis
por: Licata, Anna, et al.
Publicado: (2013)

Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation
por: Matusik, Paweł T., et al.
Publicado: (2019)

Die Biomarker BNP und NT‑proBNP
por: Oremek, G. M., et al.
Publicado: (2023)

Left atrial stiffness is superior to volume and strain parameters in predicting elevated NT-proBNP levels in systemic sclerosis patients
por: Porpáczy, Adél, et al.
Publicado: (2019)

Protecting against sedentary lifestyle, left atrial enlargement and atrial fibrillation
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2022)

Clinical impact of left atrial enlargement in Korean patients with atrial fibrillation
por: Cho, Min Soo, et al.
Publicado: (2021)

Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation
por: Hamatani, Yasuhiro, et al.
Publicado: (2016)

Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients
por: Reinhard, Henrik, et al.
Publicado: (2012)

Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients
por: Cabré, Anna, et al.
Publicado: (2013)

Prognostic value of RDW alone and in combination with NT‐proBNP in patients with heart failure
por: Liang, Lin, et al.
Publicado: (2022)

Baseline NT-Pro-BNP Levels and Arrhythmia Recurrence in Outpatients Undergoing Elective Cardioversion of Persistent Atrial Fibrillation: A Survival Analysis
por: Sanna, Tommaso, et al.
Publicado: (2009)

Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study
por: Diederichsen, S Z, et al.
Publicado: (2023)

Right atrial volume measured by cardiac magnetic resonance correlates with NT-ProBNP and invasive right atrial pressure in pulmonary hypertension, with and without systemic sclerosis
por: Gyllenhammar, Tom, et al.
Publicado: (2016)

NT-proBNP in Children With Left to Right Shunt and Dilated Cardiomyopathy
por: Koura, Hala Mahmoud, et al.
Publicado: (2016)

NT‐pro‐BNP in patients with left ventricular hypertrabeculation/non‐compaction
por: Rapatz, Katharina, et al.
Publicado: (2020)

Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling
por: Seko, Yuta, et al.
Publicado: (2018)

Serum N-Acetylneuraminic Acid Is Associated with Atrial Fibrillation and Left Atrial Enlargement
por: Hu, Wei, et al.
Publicado: (2020)

Biatrial enlargement as a predictor for reablation of atrial fibrillation
por: Kong, Qiang, et al.
Publicado: (2020)

Significance of NT-pro-BNP in acute exacerbation of COPD patients without underlying left ventricular dysfunction
por: Adrish, Muhammad, et al.
Publicado: (2017)

Agreement of BNP and NT-proBNP and the influence of clinical and laboratory variables
por: Curiati, Milena Novaes Cardoso, et al.
Publicado: (2013)

Association Between Cardiovascular Magnetic Resonance‐Derived Left Atrial Dimensions, Electroanatomical Substrate and NT‐proANP Levels in Atrial Fibrillation
por: Seewöster, Timm, et al.
Publicado: (2018)

NT-proBNP and diastolic left ventricular function in patients with Marfan syndrome
por: Gehle, Petra, et al.
Publicado: (2016)

Metabolomic profiling implicates adiponectin as mediator of a favorable lipoprotein profile associated with NT-proBNP
por: Masuch, Annette, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eptpb8bkmtan4cnjgimaah3lkd